Your browser doesn't support javascript.
loading
Extensive Histopathological Characterization of Inflamed Bowel in the Dextran Sulfate Sodium Mouse Model with Emphasis on Clinically Relevant Biomarkers and Targets for Drug Development.
Bonfiglio, Rita; Galli, Filippo; Varani, Michela; Scimeca, Manuel; Borri, Filippo; Fazi, Sara; Cicconi, Rosella; Mattei, Maurizio; Campagna, Giuseppe; Schönberger, Tanja; Raymond, Ernest; Wunder, Andreas; Signore, Alberto; Bonanno, Elena.
Afiliación
  • Bonfiglio R; Department of Experimental Medicine, University "Tor Vergata", via Montpellier 1, 00133 Rome, Italy.
  • Galli F; Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Varani M; Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Scimeca M; Department of Experimental Medicine, University "Tor Vergata", via Montpellier 1, 00133 Rome, Italy.
  • Borri F; San Raffaele University, via di Val Cannuta 247, 00166 Rome, Italy.
  • Fazi S; Saint Camillus International University of Health Sciences, via di Sant'Alessandro, 8, 00131 Rome, Italy.
  • Cicconi R; UOC Anatomia Patologica, Department of Oncology, USL Toscana Sud-Est, San Donato Hospital, 52100 Arezzo, Italy.
  • Mattei M; Department of Experimental Medicine, University "Tor Vergata", via Montpellier 1, 00133 Rome, Italy.
  • Campagna G; Interdepartmental Center for Comparative Medicine, Alternative Techniques and Aquaculture (CIMETA), University of Rome "Tor Vergata", via Montpellier 1, 00133 Rome, Italy.
  • Schönberger T; Interdepartmental Center for Comparative Medicine, Alternative Techniques and Aquaculture (CIMETA), University of Rome "Tor Vergata", via Montpellier 1, 00133 Rome, Italy.
  • Raymond E; Department of Biology, University of Rome "Tor Vergata", via della Ricerca Scientifica 1, 00133 Rome, Italy.
  • Wunder A; Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Signore A; Divison of Target Discovery Research and Target Validation Technologies, Boehringer Ingelheim Pharma GmbH & Co. KG, 88387 Biberach an der Riss, Germany.
  • Bonanno E; Immunology and Respiratory Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ridgefield, CT 06877, USA.
Int J Mol Sci ; 22(4)2021 Feb 18.
Article en En | MEDLINE | ID: mdl-33670766
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores / Enfermedades Inflamatorias del Intestino / Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores / Enfermedades Inflamatorias del Intestino / Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2021 Tipo del documento: Article País de afiliación: Italia